Once the continuous enrollment ends, it is estimated between 5 -14 million individuals will be affected
Related Posts
‘Unbelievably good price’: KC-area pharmacy dispenses bargain medicine — and hope Go to article
Around one fourth of the United States population does not have adequate health literacy.
Health literacy is defined as the ability to obtain, read, understand, and apply healthcare
information
We estimate that if the PHE expires in April 2023, 18.0 million people will lose Medicaid coverage in the following…
There are multiple factors that will impact an individual patient’s choice on how to go about getting their prescription medication. It can be overwhelming to navigate this complex issue.
St. Vincent de Paul Charitable Pharmacy offers article regarding impact of a charitable pharmacy on their community and patients
Federal/state grants are not the only gateways to funding. There are close to 750 “community foundations” nationwide which are public charities dedicated to improving the lives of people in a defined local geographic area.
The pharmacy industry sees at least five changes
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
Charitable Pharmacies of America organization member receives Health Equity grant
Want to learn more about Free and Charitable Clinics, Charitable Pharmacies and the medically underserved?
In 2011, the opioid crisis reached astounding levels with over 21,000 deaths adding to the urgency of providing aid to those who most need it
Good Pill will provide direct access to hundreds of life-saving medications and save families $150+/month on healthcare cost
Healthy People 2030 Leveraging Healthy People to Advance Health Equity Health equity is the attainment of the highest level of health for all people. “Eliminate health disparities, achieve health equity, and attain health literacy to improve the health and well-being of all.”
An opportunity for charitable pharmacies to collaborate with oncology practices for non-oncology medications during and after treatment.


